Bernard Tardy | Women’s Health | Research Excellence Award

Published on by Plant Scientist

Prof. Dr. Bernard Tardy | Women’s Health | Research Excellence Award

Clinical Investigation Center, Inserm 1408 | France

Dr Bernard Tardy is MD and Professor of Therapeutics at Université Jean Monnet (Saint-Étienne, France) and until 2018 served as Head of the Medical Intensive Care Unit at the University Hospital Center in Saint-Étienne. Since 2014 he coordinates the clinical research group INSERM CIC 1408 (Centre d’Investigation Clinique) and has since 2020 also served as a scientific advisor to HCERES (the High Council for Evaluation of Research and Higher Education), and since 2022 as scientific advisor to FCRIN (French Clinical Research Infrastructure Network). His clinical-research interests lie in anticoagulation, thrombosis, bleeding risk, haemostasis and critical care medicine, as illustrated by his recent work on bleeding risk in palliative care (the “RHESO” study), heparin-induced thrombocytopenia diagnosis and management, and thrombotic/bleeding risk in haemophilia and haematological malignancies. Over his career he has authored around 13 peer-reviewed clinical and translational research articles (as per your count), this combination has contributed to improvements in diagnosis and management of anticoagulation, patient safety, and evidence-based care.

Profile: Orcid

Featured Publications

Tardy‐Poncet, B., Montmartin, A., Chambost, H., Lienhart, A., Frotscher, B., Morange, P.-E., Falaise, C., Collange, F., Dargaud, Y., Toussaint‐Hacquard, M., Ardillon, L., Wibaut, B., Jeanpierre, E., Nguyen, P., Volot, F., & Tardy, B. (2024). Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B. Haemophilia.

Dericquebourg, A., Fretigny, M., Chatron, N., Tardy, B., Zawadzki, C., Chambost, H., Vinciguerra, C., & Jourdy, Y. (2023). Whole F9 gene sequencing identified deep intronic variations in genetically unresolved hemophilia B patients. Journal of Thrombosis and Haemostasis.

De Mazancourt, P., Harroche, A., Pouymayou, K., Sigaud, M., Falaise, C., Stieltjes, N., Castet, S.-M., Tardy, B., Zawadzki, C., & Goudemand, J. (2023). Reinvestigation of unidentified causative variants in FXI‐deficient patients: Focus on gene segment deletions. Haemophilia.

Crépin, R., Morin, C., Montmartin, A., Tardy-Poncet, B., & Chelle, P. (2021). Use of population PK/PD approach to model the thrombin generation assay: Assessment in haemophilia A plasma samples spiked by a TFPI antibody. Journal of Pharmacokinetics and Pharmacodynamics.

Lockhart, M., Tardy-Poncet, B., Montmartin, A., Noyel, P., Thouvenin, S., & Berger, C. (2021). Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors. Pediatric Blood & Cancer.